Irwin Adriane N, Heilmann Rachel M F, Gerrity Theresa M, Kroner Beverly A, Olson Kari L
Adriane N. Irwin, M.S., Pharm.D., is Clinical Assistant Professor, Oregon State University College of Pharmacy, Corvallis; at the time of writing she was Clinical Pharmacy Research Fellow, Kaiser Permanente Colorado (KPCO), Aurora. Rachel M. F. Heilmann, Pharm.D., is Clinical Pharmacy Supervisor, KPCO, Denver, and Clinical Assistant Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver. Theresa M. Gerrity, Pharm.D., is Clinical Pharmacy Specialist, KPCO, Brighton. Beverly A. Kroner, Pharm.D., is Primary Care Clinical Pharmacy Services Chief, KPCO, Aurora. Kari L. Olson, Pharm.D., is Clinical Pharmacy Supervisor, KPCO, Aurora, and Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
Am J Health Syst Pharm. 2014 Dec 1;71(23):2054-9. doi: 10.2146/ajhp140195.
The ability of a pharmacy technician to support the patient screening and documentation-related functions of a pharmacist-driven osteoporosis management service was evaluated.
A two-phase prospective study was conducted within a large integrated health system to assess a pharmacy technician's performance in supporting a multisite team of clinical pharmacy specialists providing postfracture care. In phase I of the study, a specially trained pharmacy technician provided support to pharmacists at five participating medical offices, helping to identify patients requiring pharmacist intervention and, when applicable, collecting patient-specific clinical information from the electronic health record. In phase II of the study, the amount of pharmacist time saved through the use of technician support versus usual care was evaluated.
The records of 127 patient cases were reviewed by the pharmacy technician during phase I of the study, and a pharmacist agreed with the technician's determination of the need for intervention in the majority of instances (92.9%). An additional 91 patient cases were reviewed by the technician in phase II of the research. With technician support, pharmacists spent less time reviewing cases subsequently determined as not requiring intervention (mean ± S.D., 5.0 ± 3.8 minutes per case compared with 5.2 ± 4.5 minutes under the usual care model; p = 0.78). In cases requiring intervention, technician support was associated with a reduction in the average pharmacist time spent on care plan development (13.5 ± 7.1 minutes versus 18.2 ± 16.6 minutes with usual care, p = 0.34).
The study results suggest that a pharmacy technician can accurately determine if a patient is a candidate for pharmacist intervention and collect clinical information to facilitate care plan development.
评估药剂师技术人员支持由药剂师主导的骨质疏松症管理服务中患者筛查和文件记录相关功能的能力。
在一个大型综合医疗系统内进行了一项两阶段前瞻性研究，以评估药剂师技术人员在支持多地点临床药学专家团队提供骨折后护理方面的表现。在研究的第一阶段，一名经过专门培训的药剂师技术人员为五个参与医疗办公室的药剂师提供支持，帮助识别需要药剂师干预的患者，并在适用时从电子健康记录中收集患者特定的临床信息。在研究的第二阶段，评估了通过使用技术人员支持与常规护理相比节省的药剂师时间量。
在研究的第一阶段，药剂师技术人员审查了127例患者病例记录，药剂师在大多数情况下（92.9%）同意技术人员关于干预必要性的判定。在研究的第二阶段，技术人员又审查了91例患者病例。在技术人员的支持下，药剂师随后审查被确定为不需要干预的病例所花费的时间减少（平均值±标准差，每例5.0±3.8分钟，而常规护理模式下为5.2±4.5分钟；p = 0.78）。在需要干预的病例中，技术人员的支持与药剂师在制定护理计划上花费的平均时间减少相关（13.5±7.1分钟，而常规护理为18.2±16.6分钟，p = 0.34）。
研究结果表明，药剂师技术人员可以准确确定患者是否为药剂师干预的候选对象，并收集临床信息以促进护理计划的制定。
